ReviewTherapeutic advances in medical oncology2025

Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma.

Brandon M Meyers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.